**
A recent study from Mount Sinai has unveiled concerning levels of per- and polyfluoroalkyl substances (PFAS)—commonly known as ‘forever chemicals’—in fetal blood, indicating that babies may be exposed to a greater variety of these toxic compounds than previously recognised. Testing 120 umbilical cord blood samples, researchers identified 42 different PFAS compounds, significantly exceeding prior estimates of exposure, which had primarily focused on just a handful of the most common substances.
A New Approach to Analysis
Traditionally, tests on umbilical cord blood have concentrated on a small selection of prevalent PFAS compounds, such as PFOA and PFOS. However, the new study employed a non-targeted analysis approach, which enabled researchers to detect a broader spectrum of these chemicals. Co-author Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai, emphasised the importance of these findings: “Babies are exposed to many more PFAS than we previously thought. It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
PFAS comprise a vast class of around 15,000 compounds, often used in manufacturing to create water-, stain-, and grease-resistant products. Their persistence in the environment—due to their inability to break down naturally—has led to growing concerns about their health implications. The chemicals have been linked to a range of serious health issues, including cancer, birth defects, and immune system decline.
Unpacking the Health Risks
The implications of fetal exposure to PFAS cannot be overstated. A review of 40 studies revealed that PFAS have been detected in 30,000 umbilical cord blood samples. Elevated levels of these substances in expectant mothers correlate with various adverse outcomes for newborns, including higher infant mortality rates, lower birth weights, and increased risks of obesity in later life. Moreover, prenatal exposure to these chemicals has been associated with long-term health complications such as cancer, neurological disorders, and cardiovascular disease.
The study’s findings are particularly alarming given that older PFAS compounds like PFOA and PFOS have largely been phased out in favour of newer variants. While manufacturers claim these newer chemicals are less harmful, evidence remains scant, and the environmental breakdown of PFAS can lead to the formation of entirely new compounds, complicating our understanding of their toxicity.
Regulatory Oversight Falling Short
Despite the urgency of the situation, regulatory agencies have been slow to adapt their testing methods to keep pace with the expanding array of PFAS compounds. In the United States, the Environmental Protection Agency (EPA) typically focuses on a limited number of compounds—around 30 to 40—when testing water samples. Independent research has unveiled thousands of additional PFAS in water sources, indicating a severe underestimation of the problem.
Mount Sinai’s innovative approach compared traditional testing methods with the broader non-targeted analysis, revealing that more comprehensive testing is essential in understanding the full scope of PFAS contamination. While the EPA recently certified a new blood test for 53 PFAS compounds, the Mount Sinai study identified 31 additional substances not included in this list, highlighting significant gaps in regulatory oversight.
Future Research Directions
While the current study did not directly assess the health implications of the elevated PFAS levels in fetal blood, Liu acknowledged the potential risks associated with higher concentrations. The blood samples were drawn as part of the federal government’s Home Study, which investigates PFAS exposure and its long-term health effects. Moving forward, Liu and her colleagues aim to further explore the health outcomes related to these findings.
David Andrews, acting chief science officer at the Environmental Working Group, underscored the significance of the study, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
This research sheds light on a critical public health issue, revealing the pervasive nature of PFAS exposure in prenatal development. With serious health risks linked to these chemicals, the findings call for urgent action to improve regulatory measures and testing protocols. As we uncover the extent of PFAS contamination, it becomes increasingly clear that safeguarding future generations from these ‘forever chemicals’ is not just a scientific obligation but a moral imperative. The health of our youngest citizens hangs in the balance, demanding immediate attention and robust solutions.
